Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
21/12/2023 14:40
Dec 21 (Reuters) - DMK Pharmaceuticals Corp DMK.O :
* DMK PHARMACEUTICALS REGAINS FULL RIGHTS TO COMMERCIALIZE
ZIMHI
Source text for Eikon: ID:nGNXc43ZNk
Further company coverage: DMK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update